| カタログ番号 | HB651016 |
| 宿主種 | Human |
| 種反応性 | Human |
| 形態 | Liquid |
| 保存バッファー | 0.01M PBS, pH 7.4. |
| 純度 | >95% purity as determined by SDS-PAGE. |
| クローン性 | Monoclonal |
| アイソタイプ | IgG1-kappa |
| アプリケーション | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| ターゲット | CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4 |
| 精製 | Protein A/G purified from cell culture supernatant. |
| エンドトキシンレベル | Please contact the lab for this information. |
| 発現システム | Mammalian Cells |
| アクセッション番号 | P16410 |
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | BMS-734016, MDX-010, MDX-CTLA-4, 477202-00-9 |
| 注意事項 | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Ipilimumab
概要
説明
Ipilimumab (HB651016) is a research-grade recombinant antibody targeting CD152. Produced in mammalian cells with native-like glycosylation.
Highlights
- ●Research Grade — For PK/PD studies, assay development, and ADA research.
- ●Native Glycosylation — Mammalian expression ensures native-like patterns.
イメージ
 SEC-HPLC |
SEC-HPLC detection for Research Grade Ipilimumab. |
 Bioactivity |
Detects CD152/CTLA4 in indirect ELISAs. |
 SDS-PAGE |
SDS-PAGE for Research Grade Ipilimumab |